{'fraction_non_alphanumeric': 0.032160804020100506, 'fraction_numerical': 0.006030150753768844, 'mean_word_length': 6.114285714285714, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
New Medical Technologies in a Cost Containment Environment: Implantahle Antitachyarrhythmia Devices *

A workshop on "New Medical Technologies in a Cost Containment Environment: Implantable Antitachyarrhythmia Devices," sponsored by the Institute for Health Policy Analysis, was held at the National Academy of Sciences in Washington, D.C., on June 20,1985. The Institute was joined in sponsorship of this workshop by the North American Society of Pacing and Electrophysiology, the Department of Medicine at the Georgetown University Medical Center, Office of Medical Applications of Research, National Institutes of Health, and the U.S. Food and Drug Administration. Nineteen speakers addressed the clinical, technical, economic, research and development, regulatory and approval, coverage and reimbursement, quality, and access issues surrounding the emergence of implantable devices, including pacemakers, and cardioverter-defibrillators, as clinical tools in the therapy of tachyarrhythmias.